From Sarah Haywood, MedCity’s Chief Operating Officer
All good things come to those who wait, and the official celebration of MedCity’s first year is a case in point – delayed slightly due to the general election, we joined Mayor Boris Johnson at City Hall in July to celebrate a year of intense activity and launch new research into the scale of the sector in our region (see more below). Despite the tube strike we had a great turnout, and particular thanks go to our guests from Gilead and Imanova for speaking so compellingly on what makes our region unique.
In a month of good news, special congratulations must go to our Executive Chair Eliot Forster, who has proved with great panache that it is certainly possible to raise significant funding for life sciences in the UK. You may have seen the news that, as CEO of Immunocore, he has secured investment for the company of $320m – the second largest private biotech financing in the world. You can read a great interview with the man the Sunday Times calls “the rugby playing CEO” here.